Literature DB >> 7458090

Potentiation of diffuse lung damage by oxygen: determining variables.

H R Witschi, W M Haschek, A J Klein-Szanto, P J Hakkinen.   

Abstract

The antioxidant, butylated hydroxytoluene (BHT), caused diffuse necrosis of type I alveolar cells in mouse lung followed by proliferation of type II epithelial cells. Exposure to oxygen during the phase of epithelial cell division led to the development of diffuse interstitial fibrosis. The extent of the fibrotic changes, as quantitated by measuring total lung hydroxyproline, was dependent upon both oxygen concentration in the inspired air and length of exposure. Fibrotic changes were seen in animals exposed after 400 mg/kg of BHT for 6 days to 50% oxygen or more, 3 days to 60% oxygen or more, or 2 days to 70% oxygen or more, but not if exposure was limited to 24 h only. Minimal fibrosis developed in animals exposed for 6 days to 80% oxygen alone. Additional factors determining the severity of fibrotic changes were the extent of the initial lung lesion caused by BHT and the time interval between BHT administration and the beginning of oxygen exposure. Potentiation of lung fibrosis was also observed in animals treated with methylcyclopentadienyl manganese tricarbonyl and 70% oxygen. We conclude that oxygen can severely aggravate lung damage caused by bloodborne agents, and that the severity of the resulting lesion is determined by many variables.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7458090     DOI: 10.1164/arrd.1981.123.1.98

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  13 in total

1.  Exogenous surfactant treatment for the adult respiratory distress syndrome? A historical perspective.

Authors:  N S Morton
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

Review 2.  The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond.

Authors:  Vibha N Lama; Sem H Phan
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 3.  Alveolar response to injury.

Authors:  D H Bowden
Journal:  Thorax       Date:  1981-11       Impact factor: 9.139

4.  Adult respiratory distress syndrome--II. Management.

Authors:  J H Stevens; T A Raffin
Journal:  Postgrad Med J       Date:  1984-09       Impact factor: 2.401

5.  Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis.

Authors:  T Chinet; F Jaubert; D Dusser; C Danel; J Chrétien; G J Huchon
Journal:  Thorax       Date:  1990-09       Impact factor: 9.139

6.  Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation.

Authors:  S N Iyer; D M Hyde; S N Giri
Journal:  Inflammation       Date:  2000-10       Impact factor: 4.092

7.  Intercellular adhesion molecule-1 contributes to pulmonary oxygen toxicity in mice: role of leukocytes revised.

Authors:  C D Wegner; W W Wolyniec; A M LaPlante; K Marschman; K Lubbe; N Haynes; R Rothlein; L G Letts
Journal:  Lung       Date:  1992       Impact factor: 2.584

8.  Sequelae of the adult respiratory distress syndrome.

Authors:  R Hert; R K Albert
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

9.  Postoperative pulmonary complications in patients with esophageal cancer.

Authors:  J Scholz; U Steinhöfel; M Dürig; A Prause; H W Bause; K Hamper; J Schulte am Esch
Journal:  Clin Investig       Date:  1993-04

10.  Animal model of human disease. Diffuse interstitial pulmonary fibrosis. Pulmonary fibrosis in mice induced by treatment with butylated hydroxytoluene and oxygen.

Authors:  W M Haschek; A R Brody; A J Klein-Szanto; H Witschi
Journal:  Am J Pathol       Date:  1981-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.